PRESS RELEASE: Vascular Access Catheters Market to Surpass a Valuation of US$ 3.0 Bn by end of 2022 Owing to Increasing Disease Incidences due to Growing Ageing Population

NEWARK, Del: The global vascular access catheters market is anticipated to create lucrative growth opportunities by exhibiting a CAGR of 5.7% over the forecast period from 2022 to 2032. The global market is expected to achieve a valuation of US$ 3.0 Bn by end of 2022 with a total estimation of US$ 2.2 Bn in the non-antimicrobial segment. According to Future Market Insights’ historical valuation, the global vascular access catheters market registered a CAGR of 4.9% from 2012 to 2021. The global market was valued at US$ 2.9 Bn in 2021. The growth of the market is attributed to the increasing number of cases of blood transfusions along with the rising demands of patients for central venous access. Furthermore, the rise in a number of lifestyle-related disorders and surging demand for technologically advanced vascular access devices are promising factors to propel the market in the forecast period. The aforementioned factors are expected market drivers and are anticipated to expand the market during the forecast period.

A vascular access catheter also known as a central line catheter is known as a long, thin, flexible tube utilized to draw bodily fluids and blood from veins including intravenous fluids, drugs, or blood transfusions. Central access catheters are utilized for administering medicines, fluids, nutrients, blood, and blood products. Furthermore, these catheters are used for measuring central venous pressure (CVP), hemodialysis, and chemotherapy over a long period of time. The growth of the global vascular access catheters market is primarily driven by increasing adoption and growing demand for antimicrobial coated catheters, coupled with socio-economic factors such as increasing disease incidences due to the growing aging population. Increasing cases of cancer and chronic kidney disease are major factors globally.

Owing to the technological advancements within the global vascular access catheters market within the developed regions are expected to bolster the prevalence of end-stage renal diseases and rising numbers of vascular access surgeries are the trends expanding the global vascular access catheters market. Other prominent growth drivers are product innovations and increasing rates of hospitalizations. In addition to that, product category, insertion procedure, indication, and the age of the patient are set to define the reimbursement landscape for vascular access catheters. Catheter manufacturers are expected to invest more in product design and quality to minimize the impact on patient safety.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5327

Key Takeaways

The rising implementation of tip location devices has enhanced the accuracy and efficiency of PICC and CVC insertion by helping physicians to position the PICC and CVC tip in proximity to the cardio arterial and large vein junction.

Rising demand for central venous catheters combined with favorable support from various government bodies on the basis of reimbursement and commercialization of novel interventional solutions are major factors boosting collaborations and partnership agreements between manufacturers.

Prominent companies within the central access devices market are making hefty investments to introduce innovative central venous catheters that will help in capitalizing. Therefore, creating lucrative opportunities in the vascular access catheters market. Also, companies are working on key related issues such as the prevention of thrombus formation and infection by introducing catheters with antimicrobial coatings.

The above-mentioned factors incorporate great prospects for manufacturers in order to elevate the adoption of their products to create a strong consumer base and boost the vascular access catheters market in the forecast years.
Competitive Landscape

Several advancements in biocompatibility, flexibility, and the adoption of novel materials are efficiently shaping the demand for such effective and quality products in the vascular access catheters market. Key market players in the market are looking forward to expanding their market and creating a stronghold in the consumer base from long-term vascular access catheters (VACs). Manufacturers have benefitted from the growing understanding of the diagnosis of VAC-related infections. Technological advancements especially concerning designs and materials have enabled healthcare workers to overcome complex VAC infections and complications. These factors are the prospects of new technologies in the vascular access catheter market.

Browse Full Report@ https://www.futuremarketinsights.com/reports/vascular-access-catheters-market

Key Market Segments Covered in Vascular Access Catheters Industry Research

Products:

Dialysis Catheters
Acute Hemodialysis Catheters
Chronic Hemodialysis Catheters
Peritoneal Dialysis Catheters
PICC Catheters
Implantable Port
CVC Catheters
Tunneled Catheters
Non-Tunneled Catheters
Property:

Antimicrobial Catheters
Non-Antimicrobial Catheters
Design:

Single Lumen
Double Lumen
Multiple Lumen
End User:

Hospitals
Ambulatory Surgical Centers
Dialysis Centers
Specialty Clinics and Others
Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5327

Table of Content

Executive Summary
1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

Market Overview
2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

Key Market Trends
3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

More Insights into the Vascular Access Catheters Market

The U.S. has dominated the North American vascular access catheters market in 2021 with a regional revenue share of nearly 86% and is expected to grow over a CAGR of 6.4 % during the forecast period.

The European region is anticipated to account for around 22.2% of the total market share over the projection period due to the rising number of cancer cases in the region.